Leveraging AI to optimize galectin-3 inhibitors for Alzheimer’s disease: How to move forwards
Saved in:
| Main Authors: | Huiyong Zhang, Wei Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Pharmacological Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661825002798 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy
by: Xueyan Liu, et al.
Published: (2025-08-01) -
Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
by: Anne Rombaut, et al.
Published: (2024-11-01) -
Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01) -
Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
by: Jovanović Krivokuća Milica, et al.
Published: (2024-01-01) -
Galectins: a potential pharmacological target
by: V. A. Serebryakova, et al.
Published: (2024-10-01)